Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia [Phase 2]
A Phase 2 trial evaluating ABT-925 for acute exacerbation of schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation)
A completed clinical study from Ludwig-Maximilians-Universität Munich investigates transcranial direct current stimulation (tDCS) and its ef…
-
FDA approval · 2011-04-19FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for risperidone from Aurobindo Pharma Limited, marking clearance to market this generic product.
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network [Phase 4]
Phase 4 feasibility trial completed to assess providing cognitive remediation to people with schizophrenia within a clinical network.
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Pfizer completed a Phase 3 trial evaluating varenicline (Chantix) for smoking cessation in patients with schizophrenia or schizoaffective di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia [Phase 2]
A Phase 2 trial comparing a study drug with placebo and haloperidol in patients with schizophrenia; results from the completed study were po…
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders [Phase 4]
A Phase 4 study compared clozapine with olanzapine in childhood-onset psychotic disorders, and results have been posted.
-
FDA approval · 2011-04-11FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine from Mylan Pharmaceuticals, indicating an updated or expanded use for the Clozapin…
-
FDA approval · 2011-03-30FDA Approved: RISPERIDONE — Original Application (Natco Pharma USA LLC)
FDA approved Natco Pharma USA LLC's original ANDA for risperidone, enabling a generic version of the antipsychotic. The approval allows Natc…
-
CLINICAL_TRIALS research · 2011-03-28Clinical Trial Update: Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia
Clinical trial update examining how gene polymorphisms affect metabolic features in clozapine-treated patients with schizophrenia.
-
CLINICAL_TRIALS research · 2011-03-23Clinical Trial Update: Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
A Phase 3 trial is evaluating minocycline, acetylsalicylic acid, or pramipexole versus placebo in patients with schizophrenia or schizoaffec…
-
FDA approval · 2011-03-21FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
The FDA approved a supplemental application for Fanapt (iloperidone) from Vanda Pharmaceuticals Inc., resulting in changes to the drug's lab…
-
FDA approval · 2011-03-16FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for risperidone from Jubilant Cadista Pharmaceuticals Inc., confirming continued approval of the gen…
-
CLINICAL_TRIALS research · 2011-03-08Clinical Trial Update: A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia
A retrospective non-interventional study evaluating real-world use of Seroquel XR and Seroquel IR in outpatients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016) [Phase 2]
Phase 2 trial of MK0249 for cognitive impairment in patients with paranoid schizophrenia has completed, with results posted in 2011.
-
FDA approval · 2011-03-02FDA Approved: ABILIFY — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental NDA for ABILIFY (aripiprazole) submitted by Otsuka America Pharmaceutical, Inc., to modify the product labeling …
-
FDA approval · 2011-03-01FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
The FDA approved a supplemental application for haloperidol decanoate, a long-acting injectable antipsychotic, from Patriot Pharmaceuticals …
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating the effectiveness and safety of a new medication for schizophrenia; the study is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Valproate in Late Life Schizophrenia [Phase 4]
Phase 4 clinical trial update reporting completed results for valproic acid in late-life schizophrenia; results were posted in 2011.
-
CLINICAL_TRIALS research · 2011-02-21Clinical Trial Update: Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients [NA]
This clinical trial examines whether adding metformin to clozapine-treated schizophrenia patients improves metabolic parameters. The study t…
-
CLINICAL_TRIALS research · 2011-02-21Clinical Trial Update: Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia [Phase 4]
Phase 4 clinical trial assessing adjunctive therapy with reboxetine and citalopram to second-generation antipsychotics for negative symptoms…
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Antipsychotic Therapy and First Episode [Phase 4]
Phase 4 trial evaluating antipsychotic therapy for individuals experiencing first-episode schizophrenia has completed.
-
CLINICAL_TRIALS research · 2011-02-16Clinical Trial Update: Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia [Phase 3]
This is a Phase 3 clinical trial update evaluating amantadine as an adjunctive therapy to antipsychotics in schizophrenia; the current trial…
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia [Phase 3]
Phase 3 trial of lurasidone hydrochloride for acute schizophrenia has completed. Results from the study were posted on 2011-02-14.
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia [Phase 3]
Phase 3 trial assessing the effectiveness and safety of risperidone compared with haloperidol and placebo in chronic schizophrenia; the stud…